Cargando…

Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization

PURPOSE: The aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE). METHODS: From...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuang, Donglin, Zhang, Nan, Zhang, Mengfan, Li, Hao, Han, Xinwei, Ren, Jianzhuang, Duan, Xuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110982/
https://www.ncbi.nlm.nih.gov/pubmed/37081977
http://dx.doi.org/10.3389/fonc.2023.957710
_version_ 1785027364256743424
author Kuang, Donglin
Zhang, Nan
Zhang, Mengfan
Li, Hao
Han, Xinwei
Ren, Jianzhuang
Duan, Xuhua
author_facet Kuang, Donglin
Zhang, Nan
Zhang, Mengfan
Li, Hao
Han, Xinwei
Ren, Jianzhuang
Duan, Xuhua
author_sort Kuang, Donglin
collection PubMed
description PURPOSE: The aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE). METHODS: From January 2017 to December 2020, a total of 162 patients who received a diagnosis of HCC were included in our study. We began the follow-up with magnetic resonance imaging (MRI) for complete response assessment, and peritumor margin enhancements were classified as sharp and rough types according to morphology. During the follow-up, data such as progression or remission of the two enhancement modalities, morphological changes in terms of margin enhancements observed in MR images, and alpha-fetoprotein (AFP) levels were recorded. RESULTS: In the follow-up period of 36 months, 70 and 92 patients with sharp- and rough-type peritumor margins, respectively, were observed. At the end of the follow-up, patients with sharp-type margins had lower AFP levels and longer progression-free survival than those with rough-type margins (P < 0.05). Furthermore, the sharp-type margin was thinner than the rough-type margin (all P < 0.05). Moreover, the sharp-type group had a high incidence of tumors with a diameter of < 5 cm, whereas the rough-type group had a high incidence of tumors with a diameter of ≥ 5 cm. Continuous enhancements of peritumor margins in MRI were greater in the sharp-type group than in the rough-type group. Most of the patients with a sharp-type margin achieved disease remission (94.3%, P < 0.05), whereas most of those with a rough-type margin experienced disease progression (84.8%, P < 0.05). CONCLUSIONS: Patients with HCC with a sharp-type margin enhancement on MRI after DEB-TACE mostly demonstrated benign lesions with a good prognosis, whereas those with a rough-type margin mostly demonstrated malignant growth.
format Online
Article
Text
id pubmed-10110982
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101109822023-04-19 Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization Kuang, Donglin Zhang, Nan Zhang, Mengfan Li, Hao Han, Xinwei Ren, Jianzhuang Duan, Xuhua Front Oncol Oncology PURPOSE: The aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE). METHODS: From January 2017 to December 2020, a total of 162 patients who received a diagnosis of HCC were included in our study. We began the follow-up with magnetic resonance imaging (MRI) for complete response assessment, and peritumor margin enhancements were classified as sharp and rough types according to morphology. During the follow-up, data such as progression or remission of the two enhancement modalities, morphological changes in terms of margin enhancements observed in MR images, and alpha-fetoprotein (AFP) levels were recorded. RESULTS: In the follow-up period of 36 months, 70 and 92 patients with sharp- and rough-type peritumor margins, respectively, were observed. At the end of the follow-up, patients with sharp-type margins had lower AFP levels and longer progression-free survival than those with rough-type margins (P < 0.05). Furthermore, the sharp-type margin was thinner than the rough-type margin (all P < 0.05). Moreover, the sharp-type group had a high incidence of tumors with a diameter of < 5 cm, whereas the rough-type group had a high incidence of tumors with a diameter of ≥ 5 cm. Continuous enhancements of peritumor margins in MRI were greater in the sharp-type group than in the rough-type group. Most of the patients with a sharp-type margin achieved disease remission (94.3%, P < 0.05), whereas most of those with a rough-type margin experienced disease progression (84.8%, P < 0.05). CONCLUSIONS: Patients with HCC with a sharp-type margin enhancement on MRI after DEB-TACE mostly demonstrated benign lesions with a good prognosis, whereas those with a rough-type margin mostly demonstrated malignant growth. Frontiers Media S.A. 2023-04-04 /pmc/articles/PMC10110982/ /pubmed/37081977 http://dx.doi.org/10.3389/fonc.2023.957710 Text en Copyright © 2023 Kuang, Zhang, Zhang, Li, Han, Ren and Duan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Kuang, Donglin
Zhang, Nan
Zhang, Mengfan
Li, Hao
Han, Xinwei
Ren, Jianzhuang
Duan, Xuhua
Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title_full Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title_fullStr Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title_full_unstemmed Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title_short Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
title_sort correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110982/
https://www.ncbi.nlm.nih.gov/pubmed/37081977
http://dx.doi.org/10.3389/fonc.2023.957710
work_keys_str_mv AT kuangdonglin correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT zhangnan correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT zhangmengfan correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT lihao correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT hanxinwei correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT renjianzhuang correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization
AT duanxuhua correlationbetweenmagneticresonanceimagesofperitumormarginenhancementandprognosisinhepatocellularcarcinomaafterdrugelutingbeadtranscatheterarterialchemoembolization